Javascript must be enabled to continue!
Payment for Results: Funding Non‐Profit Operations
View through CrossRef
Payment for results (PfR) funding approach, where donors reimburse the non‐profit organization (NPO) based on outcomes, is being increasingly adopted in the non‐profit sector. However, there is also concern expressed by many voluntary organizations that such a funding approach puts an undue financial burden on small NPOs and could actually be detrimental to social welfare. In this study, we build a theoretical framework to analyze PfR funding mechanisms. We use a sequential game to model the interaction between the donor and the NPO, with the donor as the first mover. This model captures how PfR funding is typically implemented in practice using social impact bonds (SIB), wherein social investors provide the upfront funding needed by the NPO to implement the project. The donor provides funding, based on the actual benefit delivered, at the end of the project and the investors are paid back using these funds. We find that higher targets set by the donor do not necessarily translate to higher expected utility or expected benefit delivered under PfR. When comparing the performance of PfR and traditional funding (TF) mechanisms, we find that the donor typically has a higher expected utility under the PfR mechanism when the probability of a negative outcome shock is either high or low, and is better off using the TF approach otherwise. When the donor’s opportunity cost of funding the project is high, the donor is better off using a PfR mechanism when her belief about the NPO having low efficiency is sufficiently high. Interestingly, we find that for a large range of parameter values there is a mismatch between the approach that gives a higher expected utility to the donor and the approach that maximizes the expected social benefit delivered. Our model and analysis suggest that the optimal funding approach, and the optimal target set under PfR, depend on the NPO’s financing cost from social investors and project outcome uncertainty.
SAGE Publications
Title: Payment for Results: Funding Non‐Profit Operations
Description:
Payment for results (PfR) funding approach, where donors reimburse the non‐profit organization (NPO) based on outcomes, is being increasingly adopted in the non‐profit sector.
However, there is also concern expressed by many voluntary organizations that such a funding approach puts an undue financial burden on small NPOs and could actually be detrimental to social welfare.
In this study, we build a theoretical framework to analyze PfR funding mechanisms.
We use a sequential game to model the interaction between the donor and the NPO, with the donor as the first mover.
This model captures how PfR funding is typically implemented in practice using social impact bonds (SIB), wherein social investors provide the upfront funding needed by the NPO to implement the project.
The donor provides funding, based on the actual benefit delivered, at the end of the project and the investors are paid back using these funds.
We find that higher targets set by the donor do not necessarily translate to higher expected utility or expected benefit delivered under PfR.
When comparing the performance of PfR and traditional funding (TF) mechanisms, we find that the donor typically has a higher expected utility under the PfR mechanism when the probability of a negative outcome shock is either high or low, and is better off using the TF approach otherwise.
When the donor’s opportunity cost of funding the project is high, the donor is better off using a PfR mechanism when her belief about the NPO having low efficiency is sufficiently high.
Interestingly, we find that for a large range of parameter values there is a mismatch between the approach that gives a higher expected utility to the donor and the approach that maximizes the expected social benefit delivered.
Our model and analysis suggest that the optimal funding approach, and the optimal target set under PfR, depend on the NPO’s financing cost from social investors and project outcome uncertainty.
Related Results
Outcomes of Transplant-Eligible Patients with Myelodysplastic Syndrome-Refractory Anemia with Excess Blasts Registered in a Prospective Observational Study: The JALSG-CS11-MDS-SCT
Outcomes of Transplant-Eligible Patients with Myelodysplastic Syndrome-Refractory Anemia with Excess Blasts Registered in a Prospective Observational Study: The JALSG-CS11-MDS-SCT
Abstract
Introduction: Allogeneic hematopoietic stem cell transplantation (allo-SCT) is the sole curative therapy for myelodysplastic syndromes (MDS). Several studie...
Comparison of Conventional Xrays with CT Based Approaches for Detection of Lytic Lesions in Multiple Myeloma
Comparison of Conventional Xrays with CT Based Approaches for Detection of Lytic Lesions in Multiple Myeloma
Background: Lytic bone lesions are one of the most common clinical characteristics of patients with multiple myeloma (MM) and identification of bone lesions help distinguish betwee...
Phase 2 Study of Tirabrutinib (ONO/GS-4059), a Second-Generation Bruton's Tyrosine Kinase Inhibitor, Monotherapy in Patients with Treatment-Naïve or Relapsed/Refractory Waldenström Macroglobulinemia
Phase 2 Study of Tirabrutinib (ONO/GS-4059), a Second-Generation Bruton's Tyrosine Kinase Inhibitor, Monotherapy in Patients with Treatment-Naïve or Relapsed/Refractory Waldenström Macroglobulinemia
BACKGROUND
Waldenström macroglobulinemia (WM) is a lymphoplasmacytic lymphoma in which bone marrow is infiltrated by immunoglobulin M (IgM)-producing clonal lymphopl...
Randomized Study of Digital Life Coaching during Autologous Stem Cell Transplantation
Randomized Study of Digital Life Coaching during Autologous Stem Cell Transplantation
Abstract
BACKGROUND: Autologous stem cell transplantation (ASCT) for multiple myeloma (MM) entails sudden life changes including acute symptom burden, changes in phy...
Trial in Progress: Phase I Open-Label Study of Metformin and Nelfinavir in Combination with Bortezomib in Patients with Relapsed and/or Refractory Multiple Myeloma
Trial in Progress: Phase I Open-Label Study of Metformin and Nelfinavir in Combination with Bortezomib in Patients with Relapsed and/or Refractory Multiple Myeloma
Abstract
Background:
GLUT4 inhibition is an attractive therapeutic option in multiple myeloma (MM) given the dependence of MM cells on glucose transpo...
FEATURES FUNCTIONING OF THE PAYMENT SYSTEM OF UKRAINE
FEATURES FUNCTIONING OF THE PAYMENT SYSTEM OF UKRAINE
In the age of the global Internet, there were changes in the life of the human community, its needs, and requirements for the provision of payment services, that, in turn, affected...
Global Trends and Directions for the Development of Digital Innovations in the Payment Services Market
Global Trends and Directions for the Development of Digital Innovations in the Payment Services Market
The article examines global trends and directions for the development of digital innovations in the payment services market; the main types of payment used in world payment systems...
Hematologic Improvement with Iron Chelation using therapy Deferasirox in Patients with Aplastic Anemia: A Subgroup Analysis of KAMS0112 Prospective Study,
Hematologic Improvement with Iron Chelation using therapy Deferasirox in Patients with Aplastic Anemia: A Subgroup Analysis of KAMS0112 Prospective Study,
Abstract
Abstract 3424
Patients with aplastic anemia (AA) are suffered from various complications related to bone marrow failure and peripheral cytope...

